![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Efficacy of 2 mg Bulevirtide in
Patients with Chronic HBV/HDV Co-Infection:
First Real-World Results
|
|
|
French Early Access Program
AASLD 2021 Nov 12-15
Victor de Ledinghen, Dominique Guyader, Sophie Metivier, Marie-Noelle Hilleret, Helène Fontaine, Bruno Roche, Nathalie Ganne-Carrie, Louis d'Alteroche, Veronique Loustaud-Ratti, Anne Gervais, Christiane Stern, Laurent Alric, Isabelle Fouchard-Hubert, Tarik Asselah, Karine Lacombe, Fabien Zoulim, Jerome Dumortier, Anne Minello, Caroline Lascoux-Combe, Leon Muti, Isabelle Ollivier-Hourmand, Dominique Larrey, Vincent Leroy, Isabelle Rosa, Julie Chas, Frederic Heluwaert, Patrick Borentain, Isabelle Archambeaud, Bernard Prouvost-Keller, Si Nafa Si Ahmed, Dominique Roulot
French collaborative study. Bordeaux, Rennes, Toulouse, Grenoble, Paris, Tours, Limoges, Angers, Lyon, Dijon, Clermont-Ferrand, Montpellier, Caen, Annecy, Marseille.
![1117211](../images/111721/111721-16/1117211.gif)
![1117212](../images/111721/111721-16/1117212.gif)
![1117213](../images/111721/111721-16/1117213.gif)
![1117214](../images/111721/111721-16/1117214.gif)
![1117215](../images/111721/111721-16/1117215.gif)
![1117216](../images/111721/111721-16/1117216.gif)
![1117217](../images/111721/111721-16/1117217.gif)
![1117218](../images/111721/111721-16/1117218.gif)
![1117219](../images/111721/111721-16/1117219.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|